Study Title
A Phase 3, randomized, double-blind, adaptive, placebo/paclitaxel-controlled study of AVB-S6-500 in combination with paclitaxel in patients with platinum-resistant recurrent ovarian cancer. (GOG 3059)
Purpose
To evaluate the effect of AVB-S6-500 plus Paclitaxel versus placebo and Paclitaxel on progression-free survival based on response evaluation criteria in solid tumors criteria, in subjects with platinum-resistant ovarian cancer.
Eligibility
Study Process
Trial Details
Investigator:
Destin Black, M.D.
IRB:
Western
IRB Number:
Trial Type:
NA
Sponsor:
Aravive
Contact Information:
Gynecologic Oncology Associates
(318) 212-8727
http://www.wkgynonc.com